| 101/314 | US=23-D / Câncer Kanematsu M, Semelka RC, Osada S. Expression of hepatocellular endothelial growth factor in hepatocellular carcinoma: correlation with radiologic findings. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 193-211. ISBN 978-1-4020-9803-1. HISTORIA DE DIAGNOSTICO RADIOLOGICO DO CARCINOMA HEPATOCELULAR; DESENVOLVIMENTO DE CARCINOMA HEPATOCELULAR |
| 102/314 | US=23-D / Câncer Kiryu S, Ohtomo K. Detection of small hepatic lesion: superparamagnetic oxide-enhanced diffusion-Weighted T2 FSE imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 213-9. ISBN 978-1-4020-9803-1. LESAO HEPATICA PEQUENA; SUPERPARAMAGNETICO OXIDO AVANCADA DIFUSAO PONDERADA T2 FSE IMAGEM; SPIO AVANCADA DWI T2 FSE IMAGEM USANDO HELICE |
| 103/314 | US=23-D / Câncer Onishi H, Murakami T, Nakumura H. Diagnosis of hepatocellular carcinoma: multidetector-row computed tomography and magnetic resonance imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 221-35. ISBN 978-1-4020-9803-1. TECNICA DE VARREDURA POR RESSONANCIA MAGNETICA; CONTRASTE DINAMICO MAIOR RESSONANCIA MAGNETICA; COMPUTADOR ANGIOTOMOGRAFIA; RESSONANCIA MAGNETICA DE CARCINOMA HEPATOCELULAR; ESTADIAMENTO DO CARCINOMA HEPATOCELULAR |
| 104/314 | US=23-D / Câncer Ichikawa T, Araki T. Hepatocellular carcinoma: effects of injection rate/injection duration of contrast material on computer tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 237-40. ISBN 978-1-4020-9803-1. CARCINOMA HEPATOCELULAR. EFEITOS DA DURACAO INJECAO TAXA; INJECCAO DE MATERIAL DE CONTRASTE EM TOMOGRAFIA COMPUTADORIZADA |
| 105/314 | US=23-D / Câncer Nishie A, Yoshimitsu K. Detection of combined hepatocellular and cholangiocarcinoma: enhanced computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 241-60. ISBN 978-1-4020-9803-1. DETECCAO DE COLANGIOCARCINOMA HEPATOCELULAR E COMBINADO; TOMOGRAFIA COMPUTADORIZADA |
| 106/314 | US=23-D / Câncer Takayasu K. Hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules): and a combination of computer tomography and angiography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 241-60. ISBN 978-1-4020-9803-1. LESOES NODULARES HEPATOCELULARES; HEPATOCARCINOGENESE; AGULHA DE BIOPSIA; CARCINOMA HEPATOCELULAR AVANCO; CARCINOMA HEPATOCELULAR PRECOCE; CARCINOMA HEPATOCELULAR NODULO; HIPO-ATENUANTES LESOES NODULARES |
| 107/314 | US=23-D / Câncer Lodato F, Davies N, Yu D, Burroughs AK. Hepatocellular cancer in cirrhotic patients: radiological imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 261-73. ISBN 978-1-4020-9803-1. TOMOGRAFIA COMPUTADORIZADA HELICOIDAL; PROBLEMAS DE PEQUENOS NODULOS |
| 108/314 | US=23-D / Câncer Hsu C, Chen CN, Cheng AL. Treatment of hepatocellular carcinoma with thalidomide: assessment with power doppler ultrasound. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 277-86. ISBN 978-1-4020-9803-1. TRATAMENTO DO CARCINOMA HEPATOCELULAR COM TALIDOMIDA; VASCULARIZACAO DO TUMOR. ULTRASSOM DOPPLER |
| 109/314 | US=23-D / Câncer Denecke T, Hildebrandt B, Lopez-Hänninen E. Perfusion scintigraphy with integrated single photon emission computed tomography / computed tomography in the management of transarterial treatment of hepatic malignancies. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 287-301. ISBN 978-1-4020-9803-1. CINTILOGRAFIA DE PERFUSAO COM EMISSAO DE FOTON UNICO; TOMOGRAFIA COMPUTADORIZADA; DOENCAS MALIGNAS HEPATICAS TRANSARTERIAL. TRATAMENTO; QUIMIOTERAPIA ARTERIAL HEPATICA; RADIOEMBOLIZACAO |
| 110/314 | US=23-D / Câncer Sun HC. Postoperative interferon alpha treatment of patients with hepatocellular carcinoma: expression of p48 using tissue microarray. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 303-10. ISBN 978-1-4020-9803-1. TRATAMENTO POS-OPERATORIO INTERFERON ALFA. PACIENTES COM CARCINOMA HEPATOCELULAR; P48 USANDO TISSUE MICROARRAY |
| 111/314 | US=23-D / Câncer Ng KTP, Man K. Hepatocellular carcinoma: overexpression of homeoprotein six 1 as a marker for predicting surgical. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 313-23. ISBN 978-1-4020-9803-1. |
| 112/314 | US=23-D / Câncer Schmid K, Mosberger I, Wrba F. Hepatocellular carcinoma: KiSS-1 overexpression as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 325-31. ISBN 978-1-4020-9803-1. CARCINOMA HEPATOCELULAR; KISS-1 SUPEREXPRESSAO COMO FATOR PROGNOSTICO |
| 113/314 | US=23-D / Câncer Nakamura H, Yoshida K, Tomita Y. Hepatocellular carcinoma: prognosis using hepatoma-derived growth factor immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 333-42. ISBN 978-1-4020-9803-1. CARCINOMA HEPATOCELULAR; HEPATOMA. FATOR DE CRESCIMENTO DERIVADO; METODOS DE IMUNO-HISTOQUIMICA; ANALITICA; HEPATOMA DERIVADO. EVOLUCAO |
| 114/314 | US=23-D / Câncer Kuramitsu Y, Nakamura K,. Hepatitis C virus-related human hepatocellular carcinoma: predictive markers using proteomic analysis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 343-50. ISBN 978-1-4020-9803-1. VIRUS DA HEPATITE C X CARCINOMA HEPATOCELULAR HUMANO; PROTEOMICA; PROTEOMICA PARA TECIDOS DE CARCINOMA HEPATOCELULAR; PROTEOMICA PARA SOROS FROW PACIENTES COM CARCINOMA HEPATOCELULAR; PROTEOMICA PARA VIRUS DA HEPATITE C TECIDOS RELACIONADOS HEPATOCELULARES |
| 115/314 | US=23-D / Câncer Rafaelsen SR. Liver metastases from colorectal cancer: ultrasound imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 355-67. ISBN 978-1-4020-9803-1. |
| 116/314 | US=23-D / Câncer Graham KC, Wirtzfeld LA, Lacefield JC, Chambers AF. Preclinical liver metastases: three-dimensional high-frequency ultrasound imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 369-86. ISBN 978-1-4020-9803-1. |
| 117/314 | US=23-D / Câncer Truant S, Huglo D, Pruvot FR. Colorectal liver metastases: 18F-fluorodeoxyglucose-positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 387-406. ISBN 978-1-4020-9803-1. METASTASES HEPATICAS COLORRETAIS; 18F-FLUORO-TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 118/314 | US=23-D / Câncer Nakanuma Y, Ikeda H, Sato Y, Harada K, Nakamura K, Zen Y. Biliary cystic tumors: clinicopathological features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 411-28. ISBN 978-1-4020-9803-1. |
| 119/314 | US=23-D / Câncer Inui K, Mioyshi H, Yoshino J. Cholangiocarcinoma: intraductal sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 429-37. ISBN 978-1-4020-9803-1. |
| 120/314 | US=23-D / Câncer Zaika AI, Hong SM. Extrahepatic bile duct carcinoma: role of the p53 protein family. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 441-9. ISBN 978-1-4020-9803-1. |